Patients with severe chronic liver, heart or kidney disease will be assessed by a health Prescriber to determine if they can receive IV therapy and that it does not interfere with any medication
Dolma, S., Lessnick, S.L., Hahn, W.C., et al
PLoS One 9 , e100627 (2014)
And in just 12 months, you'll have achieved sustainable weight loss and made lasting improvements to energy and confidence - all while still excelling in your demanding career
Who Should Avoid Peptide Therapy: Pregnant or breastfeeding women Individuals with active cancers (some peptides may stimulate cell growth) People with severe kidney or liver disease Those with untreated hormone-sensitive conditions Common Side Effects: Mild injection site reactions (for injectable peptides) Temporary water retention Mild fatigue or flu-like symptoms (usually resolves within days) At Aspire Rejuvenation, safety is our top priority
The latter is consistent with Uch-L1 improving synaptic plasticity in AD mouse models
.jpg)
